ATG5 and cancer: In a recent study by Saleh and coworkers, neither shRNAs against ATG5 nor BAF A1/HCQ treatment prior to the subsequent exposure to chemotherapeutics or radiation affected ability of cancer cells to induce senescence or recover from it (91).